Metrics to compare | FLRY3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFLRY3PeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.3x | 18.6x | −0.4x | |
PEG Ratio | 10.61 | 0.54 | 0.00 | |
Price/Book | 1.7x | 1.3x | 2.6x | |
Price / LTM Sales | 1.1x | 1.2x | 3.0x | |
Upside (Analyst Target) | 8.5% | 35.2% | 53.2% | |
Fair Value Upside | Unlock | 30.6% | 9.0% | Unlock |
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tests, fertility, infusions, and others. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.